Request Appointment
2501 N Orange AveSuite 382Orlando, FL 32804
Overview of Dr. Sonpavde
Dr. Guru Sonpavde is an oncologist based in Orlando, FL, specializing in genitourinary oncology. He completed his fellowship in Hematology and Medical Oncology at Indiana University School of Medicine and a residency in Internal Medicine at Nassau University Medical Center. Currently, he is the GU Oncology & Phase I Trials Director at AdventHealth Orlando. His expertise includes prostate, urologic, kidney, bladder, and testicular cancers. He has contributed to various publications on topics such as urologic cancer consensus and precision immuno-oncology and is involved in clinical trials for advanced urothelial and prostate cancers. Dr. Sonpavde has received CMS Meaningful Use Stage 2 Certifications through multiple healthcare technology platforms.
Education & Training
Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1995 - 1998
Nassau University Medical CenterResidency, Internal Medicine, 1992 - 1995
Christian Medical College VelloreClass of 1990
Certifications & Licensure
FL State Medical License 2022 - 2028
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification HealthSentry, Cerner Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2013, 2015-2017
Clinical Trials
- Vidaza to Restore Hormone Thx Prostate Start of enrollment: 2006 Apr 01
- Phase II Sunitinib Prog Met AIPC Start of enrollment: 2007 Mar 01
- Gemzar, Cisp, Sunitinib Urothelial Ca Start of enrollment: 2008 Aug 01
Publications & Presentations
PubMed
- Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial.Timothy A Yap, Randy F Sweis, Ulka Vaishampayan, Deepak Kilari, Justin F Gainor
Nature Medicine. 2026-01-13 - 1 citationsAdvanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.Rana R McKay, Sumanta Pal, Wanling Xie, David Aggen, Laurence Albiges
CA. 2025-12-13 - Toward a better pan-tumor predictive signature for unleashing precision immuno-oncology.Jason R Brown, Guru Sonpavde
Journal for Immunotherapy of Cancer. 2025-12-09
Journal Articles
- Development and Validation of a Prognostic Model for Overall Survival in Chemotherapy-Naïve Men with Metastatic Castration-Resistant Prostate CancerG Sonpavde, C S Higano, T M Beer, Annals of Oncology
- Treatment and Clinical Outcomes of Patients with Teratoma with Somatic-Type Malignant Transformation: An International CollaborationRichard S Foster, Lawrence H Einhorn, Christopher J Sweeney, Guru Sonpavde, Costantine Albany, Chandra K Flack, The Journal of Urology
- Nomogram to predict the benefit from salvage systemic therapy for advanced urothelial carcinoma.Sonpavde G, Pond GR, Fougeray R, Bellmunt J., BJU Int, 2014
Lectures
- 5-factor prognostic model for survival of patients with metastatic urothelial carcinoma receiving three different post-platinum PD-L1 inhibitors.2019 ASCO Annual Meeting - 6/1/2019
- A phase 3 randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) ± BMS-986205 in cisplatin-eligible muscle invasive bladder ...2019 ASCO Annual Meeting - 6/1/2019
Authored Content
- Genitourinary Medical Oncology Highlights From ESMO Congress 2025October 2025
- Genitourinary Medical Oncology Highlights From the 2025 ASCO Annual MeetingJune 2025
- PD1/L1 Inhibitor Therapy for Muscle-Invasive Bladder Cancer: Adjuvant or Neoadjuvant + Adjuvant?February 2025
Press Mentions
Innovative Spring Sees Three Groundbreaking Cardiovascular Procedures Performed by AdventHealth PhysiciansJune 4th, 2024- Groundbreaking Ozempic Study – Conducted in Part at AdventHealth – Could Increase Access for People with Chronic Kidney DiseaseMay 29th, 2024
- New Approaches in the Bladder-Sparing ParadigmMarch 20th, 2023
Professional Memberships
- Member
Insurance Accepted
- BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS PPO
First Health PPO
GHI PPO
Great West PPOHumana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
